Launch week offerEnds in00h00m00s

annual Promonthly Pro

Thomas Bartl

Medical Specialist

Medical University of Vienna

Austria

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (12)

Dan Cacsire Castillo-Tong

Group leader / Prof. Dr

Medical University of Vienna

AUSTRIA

View details

Christian Braun

Luzerner Kantonsspital

SWITZERLAND

View details

Martin Schepelmann

Group Leader / PI

Medical University of Vienna

AUSTRIA

View details

Leonhard Müllauer

Pathologist/Molecular Pathologist/Associate Professor

Medical University of Vienna

AUSTRIA

View details

Marco de Bruyn

Scientific Staff

University Medical Center Groningen

NETHERLANDS

View details

Michael Anglesio

Associate Professor

The University of British Columbia

CANADA

View details

Christoph Grimm

Medical University of Vienna

AUSTRIA

View details

Tim Dorittke

Medical University of Vienna

AUSTRIA

View details

Stephan Polterauer

Associate Professor / MD

Medical University of Vienna

AUSTRIA

View details

Matteo Marchetti

University of Padova

ITALY

View details

Johannes Knoth

Medical University of Vienna

AUSTRIA

View details

Gregg Nelson

Gynecologic Oncologist

University of Calgary

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas Bartl

Research Interests

Make your next move.

Explore related searches

Articles (20)

Arterial embolization for hemorrhage control in gynecologic malignancies: a narrative review of current evidence and unresolved questions

Lymph node involvement, surgery and adjuvant treatment in primary Endometrioid Ovarian carcinoma PAtients with eaRly-stage Disease (LEOPARD)-a multinational team initiative.

Groin Recurrence Rates After Exclusive Indocyanine Green Sentinel Node-Mapping in Early-Stage Vulvar Cancer

From Bench to Bedside beim muzinösen Ovarialkarzinom: MEK-Inhibition in Organoidmodellen und in klinischer Anwendung

Targeting RAS–RAF–MEK–ERK signaling in mucinous ovarian cancer: a translational evidence synthesis and clinical framework

Oncologic outcome of metachronous oligometastatic recurrence in advanced cervical cancer patients after primary radio-chemotherapy

Therapeutic Effects of Lurbinectedin in PARP Inhibitor-Resistant High-Grade Serous Ovarian Cancer Using Patient-Derived Cell Lines and Organoid Models

Indocyanine green fluorescence angiography for bowel anastomosis assessment in ovarian cancer surgery

Novel Treatment Concepts for Cervical Cancer—Moving Towards Personalized Therapy

The implementation and side effect management of immune checkpoint inhibitors in gynecologic oncology

Erratum: Immuntherapie bei Patientinnen mit rezidivierten Vaginalkarzinomen: Immunologisches Profiling und Klinische Wirksamkeit

Immuntherapie bei Patientinnen mit rezidivierten Vaginalkarzinomen: Immunologisches Profiling und Klinische Wirksamkeit

Oncologic and Obstetric Outcomes Following Radical Abdominal Trachelectomy in Non-Low-Risk Early-Stage Cervical Cancers: A 10-Year Austrian Single-Center Experience

Prognostic role of transcription factorARID1Ain patients with endometrial cancer of no specific molecular profile (NSMP) subtype

Novel Targeted Agents in Advanced and Recurrent Low-Grade Serous Ovarian Cancer: A Silver Lining in the Therapy of a Chemoresistant Disease?

The Predictive Value of the Fibrinogen–Albumin-Ratio Index on Surgical Outcomes in Patients with Advanced High-Grade Serous Ovarian Cancer

Diagnostic management of endometrial cancer in a single horn of a bicornuate uterus

Updates and changes in the treatment of cervical cancer

Metastasized inflammatory myofibroblastic tumor of uterine origin

Einfluss des molekularpathologischen Befundes auf Diagnose und Therapie: Fallbericht eines POLE-mutierten metastasierten Endometriumkarzinoms

Collaborators (12)

Dan Cacsire Castillo-Tong

Christian Braun

Martin Schepelmann

Leonhard Müllauer

Marco de Bruyn

Michael Anglesio

Christoph Grimm

Tim Dorittke

Stephan Polterauer

Matteo Marchetti

Johannes Knoth

Gregg Nelson

Make your next move.